Received Mar 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
ended up with COVID; ended up with COVID; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 76-year-old male patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 immunization; Bnt162b2 (DOSE 2), for COVID-19 immunization; Bnt162b2 (DOSE NUMBER UNKNOWN (BOOSTERS)), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2024, outcome "unknown" and all described as "ended up with COVID". Clinical course: the patient stated he ended up with COVID after he came back from (Withheld) and "got sick." The patient went to an urgent care the next day, and he was prescribed nirmatrelvir; ritonavir (PAXLOVID). The patient stated, he "had all the shots and all the boosters. I've had Pfizer shots for COVID, and I've had all the boosters and everything, and my only concern is I know it doesn't keep you from getting it; it just keeps you from dying from it." Therapeutic measures were taken as a result of drug ineffective, COVID-19.